

In 2022, Alyssa was offered a chance to participate in a highly experimental gene therapy trial in London. At the time, the treatment had never been successfully used on a patient in her condition. The therapy was developed by a team of researchers at Great Ormond Street Hospital and King’s College Hospital, who were exploring new ways to reprogram immune cells to fight cancer more effectively. For Alyssa, this experimental approach represented her last hope.